Skip to Main Content
 
Translator disclaimer

ABSTRACT

We are now at an amazing time for medical product development in drugs, biological products and medical devices. As a result of dramatic recent advances in biomedical science, information technology and engineering, ``big data’’ from health care in the real-world have become available. Although big data may not necessarily be attuned to provide the preponderance of evidence to a clinical study, high-quality real-world data can be transformed into scientific evidence for regulatory and healthcare decision-making using proven analytical methods and techniques, such as propensity score methodology and Bayesian inference. In this paper, we extend the Bayesian power prior approach for a single-arm study (the current study) to leverage external real-world data. We use propensity score methodology to pre-select a subset of real-world data containing patients that are similar to those in the current study in terms of covariates, and to stratify the selected patients together with those in the current study into more homogeneous strata. The power prior approach is then applied in each stratum to obtain stratum-specific posterior distributions, which are combined to complete the Bayesian inference for the parameters of interest. We evaluate the performance of the proposed method as compared to that of the ordinary power prior approach by simulation and illustrate its implementation using a hypothetical example, based on our regulatory review experience.

Acknowledgments

The first author (CW) was a consultant for the Food and Drug Administration on this project and was compensated for his consultation services. The authors are grateful to the referees for their great suggestions and comments which helped to improve the article.

A.1. Derivation of the PS-power prior for normal and binary cases

Let Yi denote the outcome of patient i (i=1,,N0) in an existing dataset.

First, consider YiN(θs,σs2) in stratum s with σs2 known. In practice, we set σs to be the standard deviation of Yi in stratum s.

The likelihood in stratum s is given by L(θs|Ds,0)=12πσs2ns,0expi=1ns,0(Yiθs)22σs2.

Note that [L(θs|Ds,0)]αsdθs=12πσs2αsns,0expi=1ns,0(YiYˉs)22σs2αsexp(θsYˉs)22σs2αsns,0dθs=12πσs2αsns,02πσs2αsns,0expi=1ns,0(YiYˉs)22σs2αs.

Thus, [L(θs|Ds,0)]αs[L(θs|Ds,0)]αsdθs=12πσs2αsns,0exp(θsYˉs)22σs2αsns,0=ϕθsYˉsσsαsns,0.

Assign π(θs)1. Then, π(θ1,,θS,v1,,vS)sϕθsYˉsσsαsns,0vsrsR.

Next, consider YiBern(θs) in stratum s. The likelihood in stratum s is given by L(θs|Ds,0)=θsns,0Yˉs(1θs)ns,0ns,0Yˉs.

Assign π(θs)=Beta(1,1). Then, L(θs|Ds,0)αsdθs=θsαsns,0Yˉs(1θs)αsns,0αsns,0Yˉsdθs=B(αsns,0Yˉs+1,αsns,0αsns,0Yˉs+1)

where B(α,β)=Γ(α)Γ(β)Γ(α+β). Thus, π(θ1,,θS,v1,,vS)sBeta(αsns,0Yˉs+1,αsns,0αsns,0Yˉs+1)vsrsR.

Login options

Purchase * Save for later
Online

Article Purchase 24 hours to view or download: USD 51.00 Add to cart

* Local tax will be added as applicable